105
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry

, , , , , , , & show all
Pages 3947-3955 | Published online: 06 Dec 2018

References

  • VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryAm J Respir Crit Care Med2017195555758228128970
  • RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
  • AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
  • HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
  • SpencerSEvansDJKarnerCCatesCJInhaled corticosteroids versus long-acting β2-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201112CD007033
  • VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • SorianoJBLamprechtBRamírezASMortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient dataLancet Respir Med20153644345025995071
  • GoossensLMLeimerIMetzdorfNBeckerKRutten-van MölkenMPDoes the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trialBMC Pulm Med20141416325326750
  • TudoricNKoblizekVMiravitllesMGOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) CohortEur Respir J2017494160251828446560
  • MenezesAMWehrmeisterFCPerez-PadillaRThe PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017Int J Chron Obstruct Pulmon Dis2017121491150128553101
  • Cabrera LópezCCasanova MacarioCMarín TrigoJMComparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on Grouping and OutcomesAm J Respir Crit Care Med2018197446346929099607
  • KahnertKAlterPYoungDThe revised GOLD 2017 COPD categorization in relation to comorbiditiesRespir Med2018134798529413512
  • GedebjergASzépligetiSKWackerhausenLHPrediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort studyLancet Respir Med20186320421229331311
  • KobayashiSHanagamaMYamandaSIshidaMYanaiMInflammatory biomarkers in asthma-COPD overlap syndromeInt J Chron Obstruct Pulmon Dis2016112117212327660429
  • KobayashiSHanagamaMYanaiMIshinomaki COPD Network (ICON) InvestigatorsEarly detection of chronic obstructive pulmonary disease in primary careIntern Med201756233153315828943559
  • The Japanese Respiratory SocietyGuidelines for the Diagnosis and Treatment of COPD (Chronic Obstructive Pulmonary Disease)4th edTokyoMedical Review Company, Ltd.2013
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management and prevention of COPD [updated 2017] Available from: http://www.goldcopd.org/Accessed November 17, 2016
  • JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
  • TsudaTSuematsuRKamoharaKDevelopment of the Japanese version of the COPD Assessment TestRespir Investig20125023439
  • MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
  • KandaYInvestigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplant201348345245823208313
  • SuzukiMMakitaHItoYMClinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort studyEur Respir J20144351289129724232696
  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
  • ConnorsAFDawsonNVThomasCOutcomes following acute exacerbation of severe chronic obstructive lung diseaseAm J Respir Crit Care Med19961544 Pt 19599678887592
  • HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
  • MüllerovaHMaselliDJLocantoreNHospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohortChest20151474999100725356881
  • LainscakMvon HaehlingSDoehnerWBody mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary diseaseJ Cachexia Sarcopenia Muscle201122818621766053
  • LeeSDHuangMSKangJThe COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patientsRespir Med2014108460060824456695